• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺激素通过一个远距离转录增强子控制核因子κB受体激活蛋白配体基因的表达。

Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer.

作者信息

Fu Qiang, Manolagas Stavros C, O'Brien Charles A

机构信息

University of Arkansas for Medical Sciences, 4301 W. Markham St., Mail Slot 587, Little Rock, AR 72205, USA.

出版信息

Mol Cell Biol. 2006 Sep;26(17):6453-68. doi: 10.1128/MCB.00356-06.

DOI:10.1128/MCB.00356-06
PMID:16914731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1592840/
Abstract

RANKL, a protein essential for osteoclast development and survival, is stimulated by parathyroid hormone (PTH) via a PTH receptor 1/cyclic AMP (cAMP)/protein kinase A (PKA)/CREB cascade, exclusively in osteoblastic cells. We report that a bacterial artificial chromosome-based transcriptional reporter construct containing 120 kb of RANKL 5'-flanking region was stimulated by dibutyryl-cAMP in stromal/osteoblastic cells, but not other cell types. Full cAMP responsiveness was dependent upon a conserved 715-bp region located 76 kb upstream from the transcription start site, which we identified by sequential deletion analysis and by comparison of human and mouse genomic sequences in silico. This region contained conserved consensus sequences which bound CREB and the osteoblast-specific transcription factor Runx2, and when mutated blunted cAMP responsiveness. Overexpression of Runx2 potentiated cAMP responsiveness of the endogenous RANKL gene in a cell-type-specific manner. Lastly, PTH responsiveness of the endogenous RANKL gene was abrogated in mice from which we deleted this conserved upstream region. Thus, PTH responsiveness of the RANKL gene is determined by a distant regulatory region that responds to cAMP in a cell-type-specific manner and Runx2 may contribute to such cell-type specificity.

摘要

核因子κB受体活化因子配体(RANKL)是破骨细胞发育和存活所必需的一种蛋白质,甲状旁腺激素(PTH)通过PTH受体1/环磷酸腺苷(cAMP)/蛋白激酶A(PKA)/CREB级联反应,仅在成骨细胞中刺激RANKL。我们报告,一个基于细菌人工染色体的转录报告构建体,包含120 kb的RANKL 5'侧翼区域,在基质/成骨细胞中被二丁酰环磷腺苷(dibutyryl-cAMP)刺激,但在其他细胞类型中未被刺激。完整的cAMP反应性依赖于位于转录起始位点上游76 kb处的一个保守的715 bp区域,我们通过序列缺失分析以及通过在计算机上比较人和小鼠的基因组序列确定了该区域。该区域包含与CREB和成骨细胞特异性转录因子Runx2结合的保守共有序列,当发生突变时会减弱cAMP反应性。Runx2的过表达以细胞类型特异性方式增强了内源性RANKL基因的cAMP反应性。最后,在我们删除了这个保守上游区域的小鼠中,内源性RANKL基因的PTH反应性被消除。因此,RANKL基因的PTH反应性由一个远距离调控区域决定,该区域以细胞类型特异性方式对cAMP作出反应,并且Runx2可能有助于这种细胞类型特异性。

相似文献

1
Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer.甲状旁腺激素通过一个远距离转录增强子控制核因子κB受体激活蛋白配体基因的表达。
Mol Cell Biol. 2006 Sep;26(17):6453-68. doi: 10.1128/MCB.00356-06.
2
Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.环磷酸腺苷/蛋白激酶A介导甲状旁腺激素/甲状旁腺激素相关蛋白受体对破骨细胞生成以及骨髓基质细胞中核因子κB受体活化因子配体(RANKL)和骨保护素mRNA表达的调控。
J Bone Miner Res. 2002 Sep;17(9):1667-79. doi: 10.1359/jbmr.2002.17.9.1667.
3
Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.甲状旁腺激素通过环磷酸腺苷反应元件结合蛋白的蛋白激酶A激活作用刺激核因子κB受体激活蛋白配体,并抑制骨保护素表达。
J Biol Chem. 2002 Dec 13;277(50):48868-75. doi: 10.1074/jbc.M208494200. Epub 2002 Oct 2.
4
Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice.成骨细胞谱系细胞中参与甲状旁腺激素介导的核因子κB受体活化因子配体(RANKL)表达的远端肿瘤坏死因子配体超家族成员11(Tnfsf11)RL-D2增强子的缺失导致小鼠出现高骨量表型。
J Bone Miner Res. 2016 Feb;31(2):416-29. doi: 10.1002/jbmr.2698.
5
Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers.1,25-二羟维生素D3对核因子-κB受体激活剂配体基因表达的激活作用是通过多个远程增强子介导的。
Mol Cell Biol. 2006 Sep;26(17):6469-86. doi: 10.1128/MCB.00353-06.
6
Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers.蛋白激酶A激活剂福斯高林和跨膜糖蛋白130激活细胞因子抑瘤素M对核因子-κB配体受体激活剂的转录调控是通过多个远端增强子实现的。
Mol Endocrinol. 2007 Jan;21(1):197-214. doi: 10.1210/me.2006-0315. Epub 2006 Oct 19.
7
Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast.活性氧刺激成骨细胞中核因子κB受体激活因子配体的表达。
J Biol Chem. 2005 Apr 29;280(17):17497-506. doi: 10.1074/jbc.M409332200. Epub 2005 Feb 24.
8
Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family.环磷酸腺苷反应元件结合蛋白家族成员对类固醇生成及类固醇生成急性调节蛋白的调控
Mol Endocrinol. 2002 Jan;16(1):184-99. doi: 10.1210/mend.16.1.0759.
9
Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.表达重组甲状旁腺激素/甲状旁腺激素相关蛋白受体的SaOS-4/3细胞支持的破骨细胞生成中膜相关或基质相关形式的巨噬细胞集落刺激因子和核因子κB受体活化因子配体/骨保护素的重要性。
J Bone Miner Res. 2000 Sep;15(9):1766-75. doi: 10.1359/jbmr.2000.15.9.1766.
10
Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter.维生素D3通过人RANKL基因启动子的功能性维生素D反应元件支持破骨细胞生成。
J Cell Biochem. 2003 Jul 1;89(4):771-7. doi: 10.1002/jcb.10567.

引用本文的文献

1
Severe Hypocalcemia During JAK1/2 Inhibitor Therapy for Myelofibrosis in a Patient with Liver Cirrhosis.一名肝硬化患者在接受JAK1/2抑制剂治疗骨髓纤维化期间发生严重低钙血症
Intern Med. 2025 Aug 1;64(15):2338-2343. doi: 10.2169/internalmedicine.4723-24. Epub 2025 Jan 15.
2
Roles of osteoclasts in pathological conditions.破骨细胞在病理状态下的作用。
Pathol Int. 2025 Feb;75(2):55-68. doi: 10.1111/pin.13500. Epub 2024 Dec 20.
3
Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions.乳腺癌骨转移的预测和预后生物标志物:现状与未来方向
Cell Biosci. 2023 Dec 1;13(1):224. doi: 10.1186/s13578-023-01171-8.
4
Effects of PTH on osteoblast bioenergetics in response to glucose.甲状旁腺激素(PTH)对成骨细胞响应葡萄糖时生物能量学的影响。
Bone Rep. 2023 Jul 24;19:101705. doi: 10.1016/j.bonr.2023.101705. eCollection 2023 Dec.
5
Identification of an intronic enhancer regulating RANKL expression in osteocytic cells.鉴定调控骨细胞中RANKL表达的内含子增强子。
Bone Res. 2023 Aug 11;11(1):43. doi: 10.1038/s41413-023-00277-6.
6
Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis.慢性肾脏病骨病的病理生理学:从基础到肾性骨营养不良和骨质疏松症。
Front Physiol. 2023 Jun 5;14:1177829. doi: 10.3389/fphys.2023.1177829. eCollection 2023.
7
Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study.地诺单抗治疗骨巨细胞瘤(GCTB)后骨转换标志物(BTM)的变化:一项II期试验相关研究
Cancers (Basel). 2022 Jun 10;14(12):2863. doi: 10.3390/cancers14122863.
8
The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies.乳腺癌转移的基因组结构:聚焦机制、信号通路及治疗策略
Med Oncol. 2021 Jul 16;38(8):95. doi: 10.1007/s12032-021-01547-1.
9
Deletion of a putative promoter-proximal Tnfsf11 regulatory region in mice does not alter bone mass or Tnfsf11 expression in vivo.在小鼠中删除假定的 Tnfsf11 启动子近端调控区不会改变体内骨量或 Tnfsf11 的表达。
PLoS One. 2021 May 10;16(5):e0250974. doi: 10.1371/journal.pone.0250974. eCollection 2021.
10
SLPI is a critical mediator that controls PTH-induced bone formation.SLPI 是一种关键的介质,可控制 PTH 诱导的骨形成。
Nat Commun. 2021 Apr 9;12(1):2136. doi: 10.1038/s41467-021-22402-x.

本文引用的文献

1
Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers.1,25-二羟维生素D3对核因子-κB受体激活剂配体基因表达的激活作用是通过多个远程增强子介导的。
Mol Cell Biol. 2006 Sep;26(17):6469-86. doi: 10.1128/MCB.00353-06.
2
Parathyroid hormone: past and present.甲状旁腺激素:过去与现在。
J Endocrinol. 2005 Dec;187(3):311-25. doi: 10.1677/joe.1.06057.
3
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.核因子κB受体活化因子配体(RANKL)在生理性和病理性骨吸收中的作用以及针对RANKL-RANK信号系统的治疗方法。
Immunol Rev. 2005 Dec;208:30-49. doi: 10.1111/j.0105-2896.2005.00327.x.
4
IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice.白细胞介素-6并非小鼠甲状旁腺激素刺激核因子κB受体活化因子配体表达、破骨细胞形成及骨质流失所必需。
Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E784-93. doi: 10.1152/ajpendo.00029.2005. Epub 2005 Jun 14.
5
Prediction of cis-regulatory elements using binding site matrices--the successes, the failures and the reasons for both.使用结合位点矩阵预测顺式调控元件——成功、失败及其原因
Curr Opin Genet Dev. 2005 Aug;15(4):395-402. doi: 10.1016/j.gde.2005.05.002.
6
Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3.使用细菌人工染色体微阵列进行的表观基因组分析确定了SHANK3基因组织特异性甲基化的进化保守性。
Nat Genet. 2005 Jun;37(6):645-51. doi: 10.1038/ng1563. Epub 2005 May 15.
7
Leptin regulation of bone resorption by the sympathetic nervous system and CART.瘦素通过交感神经系统和可卡因-安非他明调节转录肽对骨吸收的调节作用。
Nature. 2005 Mar 24;434(7032):514-20. doi: 10.1038/nature03398. Epub 2005 Feb 20.
8
1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.1,25-二羟基维生素D3刺激完整成骨细胞中环状维生素D受体/视黄酸X受体的DNA结合、共激活因子募集和组蛋白乙酰化。
J Bone Miner Res. 2005 Feb;20(2):305-17. doi: 10.1359/JBMR.041112. Epub 2004 Nov 16.
9
Comparative genomics using fugu: a tool for the identification of conserved vertebrate cis-regulatory elements.利用河豚进行比较基因组学研究:一种鉴定保守脊椎动物顺式调控元件的工具。
Bioessays. 2005 Jan;27(1):100-7. doi: 10.1002/bies.20134.
10
NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes.核因子Y(NF-Y)对于RNA聚合酶II的募集以及几个含有CCAAT框的基因的诱导转录至关重要。
Mol Cell Biol. 2005 Jan;25(1):512-22. doi: 10.1128/MCB.25.1.512-522.2005.